Abstract
Phenylketonuria (PKU), one of the most prevalent autosomal recessive disorders of amino acid metabolism, is characterized by abnormal accumulation of phenylalanine, which can lead to intellectual disability. The main pathologic changes in the central nervous system of untreated phenylketonuric patients are reductions in the number of axons, dendrites, and synapses in the brain. Such alterations are thought to be mainly associated with the toxic effects caused by phenylalanine. However, the underlying molecular mechanisms have not been fully elucidated. The present study shows that a high concentration of phenylalanine remarkably inhibited neuronal neurite formation in vitro. Interestingly, AMP-activated protein kinase (AMPK), the energy status sensor, was activated in cultured cerebral cortical neurons upon phenylalanine treatment. Pretreatment with an AMPK inhibitor ameliorated the reduction of neurite formation caused by phenylalanine. In addition, the levels of the phosphorylated AMPK, the active form of AMPK, were significantly higher in the cerebral cortices of PKU mice with elevated phenylalanine levels in this brain region compared to those in wild-type control mice, whereas the density of dendritic spines on basal secondary dendrites of pyramidal neurons in prefrontal cortices of PKU mice was significantly decreased. Collectively, these findings indicate that AMPK activation is a key event in impaired neuronal dendritic development in PKU and consequently, a potential therapeutic target for developing neuroprotective strategies against phenylalanine-evoked brain injury in PKU.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andolina D, Conversi D, Cabib S et al (2011) 5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria. Int J Neuropsychopharmacol 14:479–489
Brown RE, Wilkinson PM, Imran SA et al (2009) Resistin differentially modulates neuropeptide gene expression and AMP-activated protein kinase activity in N-1 hypothalamic neurons. Brain Res 1294:52–60
Cai Y, Weng K, Guo Y et al (2015) An integrated targeted metabolomic platform for high-throughput metabolite profiling and automated data processing. Metabolomics 11:1575–1586
Cantó C, Auwerx J (2011) Calorie restriction: is AMPK a key sensor and effector? Physiology 26:214–224
Ercal N, Aykin-Burns N, Gurer-Orhan H et al (2002) Oxidative stress in a phenylketonuria animal model. Free Radic Biol Med 32:906–911
Gowans GJ, Hardie DG (2014) AMPK: a cellular energy sensor primarily regulated by AMP. Biochem Soc Trans 42:71–75
Hardie DG (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774–785
Hartwig C, Gal A, Santer R et al (2006) Elevated phenylalanine levels interfere with neurite outgrowth stimulated by the neuronal cell adhesion molecule L1 in vitro. FEBS Lett 580:3489–3492
Hörster F, Schwab MA, Sauer SW et al (2006) Phenylalanine reduces synaptic density in mixed cortical cultures from mice. Pediatr Res 59:544–548
Huttenlocher PR (2000) The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 159(Suppl 2):S102–S106
Ito D, Tamate H, Nagayama M et al (2010) Minimum neuron density for synchronized bursts in a rat cortical culture on multi-electrode arrays. Neuroscience 171:50–61
Ju TC, Chen HM, Chen YC et al (2014) AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington’s disease. Biochim Biophys Acta 1842:1668–1680
Lee ES, Uhm KO, Lee YM et al (2008) Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway. Regul Pept 151:71–74
Lee KY, Kim JR, Choi HC (2016) Genistein-induced LKB1-AMPK activation inhibits senescence of VSMC through autophagy induction. Vasc Pharmacol 81:75–82
Li D, Gu X, Lu L et al (2010) Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor. Mol Cell Biochem 339:1–7
Lu L, Gu X, Li D et al (2011) Mechanisms regulating superoxide generation in experimental models of phenylketonuria: an essential role of NADPH oxidase. Mol Genet Metab 104:241–248
Lu J, Cao Y, Cheng K et al (2015) Berberine regulates neurite outgrowth through AMPK-dependent pathways by lowering energy status. Exp Cell Res 334:194–206
Mairet-Coello G, Courchet J, Pieraut S et al (2013) The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through tau phosphorylation. Neuron 78:94–108
Marin JJ, Lozano E, Perez MJ (2016) Lack of mitochondrial DNA impairs chemical hypoxia-induced autophagy in liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation independently of HIF-1α. Free Radic Biol Med 101:71–84
Moraes TB, Zanin F, da Rosa A et al (2010) Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain. J Neurol Sci 292:89–95
Oruganty-Das A, Ng T, Udagawa T et al (2012) Translational control of mitochondrial energy production mediates neuron morphogenesis. Cell Metab 16:789–800
Pietz J, Rupp A, Ebinger F et al (2003) Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P MR spectroscopy. Pediatr Res 53:654–662
Rajamohan F, Reyes AR, Frisbie RK et al (2016) Probing the enzyme kinetics, allosteric modulation and activation of α1- and α2-subunit-containing AMP-activated protein kinase (AMPK) heterotrimeric complexes by pharmacological and physiological activators. Biochem J 473:581–592
Ramamurthy S, Chang E, Cao Y et al (2014) AMPK activation regulates neuronal structure in developing hippocampal neurons. Neuroscience 259:13–24
Reddy PH (2011) Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer’s disease. Brain Res 1415:136–148
Sanayama Y, Nagasaka H, Takayanagi M et al (2011) Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab 103:220–225
Sarre A, Gabrielli J, Vial G et al (2012) Reactive oxygen species are produced at low glucose and contribute to the activation of AMPK in insulin-secreting cells. Free Radic Biol Med 52:142–150
Schlegel G, Scholz R, Ullrich K et al (2016) Phenylketonuria: direct and indirect effects of phenylalanine. Exp Neurol 281:28–36
Seixas da Silva GS, Melo HM, Lourenco MV et al (2017) Amyloid-β oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. J Biol Chem 292:7395–7406
Susick LL, Lowing JL, Provenzano AM et al (2014) Postnatal ethanol exposure simplifies the dendritic morphology of medium spiny neurons independently of adenylyl cyclase 1 and 8 activity in mice. Alcohol Clin Exp Res 38:1339–1346
Vogel KR, Arning E, Bottiglieri T et al (2017) Multicompartment analysis of protein-restricted phenylketonuric mice reveals amino acid imbalances in brain. J Inherit Metab Dis 40:227–235
Wakita S, Izumi Y, Nakai T et al (2014) Staurosporine induces dopaminergic neurite outgrowth through AMP-activated protein kinase/mammalian target of rapamycin signaling pathway. Neuropharmacology 77:39–48
Xu SY, Wu YM, Ji Z et al (2012) A modified technique for culturing primary fetal rat cortical neurons. J Biomed Biotechnol 2012:803930
Xu Y, Liu C, Chen S et al (2014) Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson’s disease. Cell Signal 26:1680–1689
Acknowledgements
We thank Professor Junhao Hu for providing critical suggestions.
Funding
This work was funded by the grant from the National Natural Science Foundation of China (No. 81300708).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
L. Lu, X. Ben, L. Xiao, M. Peng, and Y. Zhang declare that they have no conflict of interest.
Animal rights
All institutional and national guidelines for the care and use of laboratory animals were followed. This article does not contain any studies with human subjects performed by any of the authors.
Additional information
Communicated by: John Christodoulou
Rights and permissions
About this article
Cite this article
Lu, L., Ben, X., Xiao, L. et al. AMP-activated protein kinase activation in mediating phenylalanine-induced neurotoxicity in experimental models of phenylketonuria. J Inherit Metab Dis 41, 679–687 (2018). https://doi.org/10.1007/s10545-017-0115-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-017-0115-6